MS can substantially and adversely affect an individual’s quality of life (QOL) and is associated with high costs for MS patients, their families, and society as a whole.
A key issue for policy makers and advocacy organizations is the cost to society of MS. Cost of illness studies quantify the economic burden of specific diseases and can be used by policy makers to allocate research and service funding. Several cost of illness estimates for MS in many different countries have been published over the past 10 years, with all finding a high cost on a per person basis.
To help raise awareness of the high global costs of MS, the MS International Federation produced a literature review with international data useful for estimating the costs and QOL impacts of MS at the national level. This review was a focal point for the World MS Day campaign in 2010.
A companion report includes a cost calculator that can be used to estimate the economic impact of MS at the country level.
The Atlas of MS also captured data on the cost of treatment (a component of economic impact) that can be used for advocacy purposes.